B. contaminans is the most frequent species of the B. cepacia complex (Bcc) isolated from CF patients in Argentina. There is little data on the virulence and clinical impact of this Bcc member over CF patients' health. To assess characteristics of B. contaminans associated with different courses of infection, colonies recovered from A) patients with a unique isolate (n = 3) and B) first and last isolates of chronically infected patients (n = 3), were compared. Two patients of this last group died. RAPD genetic comparation, antibiotics resistance profile, virulence on the alfalfa model, biofilm formation, motility, haemolysis, green-yellow pigment and mucoid phenotype were studied. Colonies recovered from A and first isolates from B were very similar and displayed haemolytic activity, pigment production, and mucoid expression. Among last isolates collected from the two dead patients, some colonies with nonmucoid phenotype, low motility and biofilm formation, no haemolytic activity nor pigment production were found. There were no significant differences of virulence in the alfalfa model assays. Main differences were found in RAPD and the antibiotic resistance profiles: colonies collected from A group shared the same RAPD pattern and were susceptible to all antibiotics tested. However, only one colony of the first isolate from B group had this antibiotic profile. First and last isolates of the two dead patients showed genetic changes. These results suggest genetic and phenotypic changes during the course of the infection by B. contaminans. Although a phenotype was detected at the last stage of infection, more virulence related to the alfalfa model could not be demonstrated. aureus from the patient sputa revealed that as many as 40% of culture-negative samples were positive by PCR. The isolates were typed by pulsed-field gel electrophoresis (PFGE) and spa typing and some of them also by multilocus sequence typing. All isolates studied were of unique types. A small proportion of the MRSA isolates analyzed (n = 3) showed an identical PFGE pattern and the same spa type. Around one third of the isolates were resistant to MLSB antibiotics while aminoglycoside resistance was much less frequent. The isolates were screened for MLSB resistance genes (ermA, ermB, ermC and msrA) and aminoglycoside resistance genes (aacA-aphD, aphA3, aadC). In a large proportion (around one third) of the isolates, none of these resistance genes was detected. SCV strains, all but one auxotrophic to thymidine. Objectives: CF lung disease is associated with diverse bacteria chronically infecting the airways. Slow-growing, antibiotic-resistant mutants of S. aureus known as small-colony variants (SCVs) have been isolated from respiratory secretions from European adults and children with CF using specific but infrequently-used culture techniques. S. aureus SCVs can be selected either by exposure to specific antibiotics or by growth with P. aeruginosa. We sought to determine the prevalence, clinical significance, and likely mechanisms of selection of S. aureus SCVs among a US cohort of children with CF. Methods: We performed a two-year study of 100 children with CF using culture techniques sensitive for S. aureus SCVs, and evaluated associations with clinical characteristics using multivariable regression models. Results: S. aureus SCV infection was detected among 24% of participants and was significantly associated with a much greater lung function decline during the study (p = 0.007, adjusted for enrollment age and lung function), even after adjusting for infection with other known CF pathogens, including P. aeruginosa and methicillin-resistant S. aureus. Evidence indicated S. aureus SCVs were selected in vivo by treatment with trimethoprim-sulfamethoxazole and by co-infection with P. aeruginosa. Conclusion: SCV S. aureus infection was independently associated with poorer CF respiratory outcomes in this pediatric cohort. As many clinical microbiology laboratories do not specifically detect S. aureus SCVs, validation and extension of these findings would require widespread changes in the usual laboratory and clinical approach to these bacteria.
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